Natural products: A continuing source of novel drug leads

Biochimica et Biophysica Acta - General Subjects

Volumn 1830, Issue 6, 2013, Pages 3670-3695

  Cragg, Gordon M ^a   Newman, David J ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

genomics; Microbial diversity; natural product drugs; synthesis

Indexed keywords

ANSAMITOCIN; ANTINEOPLASTIC AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTEROLANE; BLEOMYCIN; BLEOMYCIN A2; BLEOMYCIN B2; BRYOSTATIN I; CABAZITAXEL; CHLOROQUINE; CISPLATIN; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPHEDRINE; HALICHONDRIN B; MAYTANSINE; MEFLOQUINE; NATURAL PRODUCT; OMEGA CONOTOXIN MVIIA; OZ 2777; PACLITAXEL; QUININE; RESERPINE; RIFAMPICIN; TRABECTEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE;

ACTINOSYNNEMA PRETIOSUM; ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTEMISIA ANNUA; ASTHMA; BIOSYNTHESIS; BREAST CANCER; CAMPTOTHECA ACUMINATA; CANCER RECURRENCE; CATHARANTHUS ROSEUS; CINCHONA OFFICINALIS; CULTURE TECHNIQUE; DRUG APPROVAL; DRUG DESIGN; DRUG DETERMINATION; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOLERABILITY; ECTEINASCIDIN TURBINATA; ENDOPHYTE; EPHEDRA SINICA; FOOD AND DRUG ADMINISTRATION; GENOME ANALYSIS; GENOMICS; HUMAN; LIPOSARCOMA; MALARIA; MALIGNANT NEOPLASTIC DISEASE; MARINE ENVIRONMENT; MARINE SPECIES; MAYTENUS SERRATA; MEDICINAL PLANT; METASTASIS; MICROBIAL DIVERSITY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RAUWOLFIA; REVIEW; SOFT TISSUE SARCOMA; TRADITIONAL MEDICINE; UNSPECIFIED SIDE EFFECT; UROCHORDATA;

ANIMALS; BACTERIA; CLONING, MOLECULAR; DRUG DISCOVERY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PLANTS;

ANIMALIA;

EID: 84876002671     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.02.008     Document Type: Review

References (254)

1. J.K. Borchardt The beginnings of drug therapy: Ancient mesopotamian medicine Drug News Perspect. 15 2002 187 192
2. K.C. Huang The pharmacology of chinese herbs 2nd ed. 1999 CRC Press Boca Raton, FL
3. L.D. Kapoor CRC handbook of ayurvedic medicinal plants 1990 CRC Press Boca Raton, FL
4. S. Dev Ancient-modern concordance in ayurvedic plants: Some examples Environ. Health Perspect. 107 1999 783 789
5. D.E. Moerman Medicinal plants of native America 1986 University of Michigan Museum of Anthropology Ann Arbor, MI
6. T. Johnson CRC ethnobotany desk reference 1999 CRC Press Boca Raton, FL
7. N.R. Farnsworth, R.O. Akerele, A.S. Bingel, D.D. Soejarto, and Z. Guo Medicinal plants in therapy Bull. World Health Organ. 63 1985 965 981
8. D.S. Fabricant, and N.R. Farnsworth The value of plants used in traditional medicine for drug discovery Environ. Health Perspect. 109 2001 69 75 (supplement)
9. A.D. Buss, and R.D. Waigh Natural products as leads for new pharmaceuticals M.E. Wolff, Burger's medicinal chemistry and drug discovery. Principles and practice vol. 1 1995 John Wiley & Sons, Inc. New York, NY 983 1033
10. C. Wongsrichanalai, A.L. Pickard, W.H. Wernsdorfer, and S.R. Meshnick Epidemiology of drug-resistant malaria Lancet Infect. Dis. 2 2002 209 218
11. D.L. Klayman, A.J. Lin, N. Acton, J.P. Scovill, J.M. Hoch, W.K. Milhous, and A.D. Theoharides Isolation of artemisinin (qinghaosu) from artemisia annua growing in the United States J. Nat. Prod. 47 1985 715 717
12. D.L. Klayman Qinghaosu (artemisinin): An antimalarial drug from China Science 228 1985 1049 1055
13. L.H. Miller, and X. Su Atermisinin: Discovery from the Chinese herbal garden Cell 146 2011 855 858
14. P.M. O'Neill, and G.H. Posner A medicinal chemistry perspective on artemisinin and related endoperoxides J. Med. Chem. 47 2004 2945 2964
15. P.M. O'Neill, V.E. Barton, and S.A. Ward The molecular mechanism of action of artemisinin - the debate continues Molecules 15 2010 1705 1721
16. J. Wang, L. Huang, J. Li, Q. Fan, Y. Long, Y. Li, and B. Zhou Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation PLoS One 5 2010 e9582
17. J.L. Vennerstrom, S. Arbe-Barnes, R. Brun, S.A. Charman, F.C.K. Chiu, J. Chollet, Y. Dong, A. Dorn, D. Hunziker, H. Matile, K. McIntosh, M. Padmanilayam, J. Santo Tomas, C. Scheurer, B. Scorneaux, Y. Tang, H. Urwyler, W. Sergio, and W.N. Charman Identification of an antimalarial synthetic trioxolane drug development candidate Nature 430 2004 900 904
18. G.H. Posner, I.-H. Paik, W. Chang, K. Borstnik, S. Sinishtaq, A.S. Rosenthal, and T.A. Shapiro Malaria-infected mice are cured by a single dose of novel artemisinin derivatives J. Med. Chem. 50 2007 2516 2519
19. G.A. Cordell, and M.D. Colvard Natural products and traditional medicine: Turning on a paradigm J. Nat. Prod. 75 2012 514 525
20. J.L. Hartwell Plants used against cancer 1982 Quarterman Lawrence, MA
21. G.M. Cragg, M.R. Boyd, J.H. Cardellina II, D.J. Newman, K.M. Snader, and T.G. McCloud Ethnobotany and drug discovery: The experience of the US National Cancer Institute D.J. Chadwick, J. Marsh, Ethnobotany and the search for new drugs, ciba foundation symposium, vol vol. 185 1994 John Wiley & Sons, Inc. New York, NY 178 196
22. F. Gueritte, and J. Fahy The vinca alkaloids G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 123 135
23. F. Roussi, F. Gueritte, and J. Fahy The vinca alkaloids G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 177 198
24. K.-H. Lee, and Z. Xiao Podophyllotoxin and analogs G.M.K. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, Fl 71 87
25. K.-H. Lee, and Z. Xiao Podophyllotoxin and analogs G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 95 122
26. D.G.I. Kingston Taxol and its analogs G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 89 122
27. D.G.I. Kingston Taxol and its analogs G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, Fl 123 175
28. P.B. Schiff, and S.B. Horwitz Taxol stabilizes microtubules in mouse fibroblast cells Proc. Natl. Acad. Sci. U. S. A. 77 1980 1561 1565
29. M.R. Green, G.M. Manikhas, S. Orlov, B. Afanasyev, A.M. Makhson, P. Bhar, and M.J. Hawkins Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer Ann. Oncol. 17 2006 1263 1268
30. A.C. Burman, R. Mukherjee, D. Khattar, M. Kumar, H. Bala, R.K. Shrivastava, Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles, in: Patent EP 1216042, 12JUN2000.
31. D.G.I. Kingston, and D.J. Newman Taxoids: Cancer-fighting compounds from nature Curr. Opin. Drug Discov. Dev. 10 2007 130 144
32. N.J. Rahier, C.J. Thomas, and S.M. Hecht Camptothecin and its analogs G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 5 21
33. A. Kirschning, K. Harmrolfs, and T. Knobloch The chemistry and biology of the maytansinoid antitumor agents C. R. Chimie 11 2008 1523 1543
34. J.-W. Yu, H.G. Floss, G.M. Cragg, and D.J. Newman Ansamitocins (maytansenoids) G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 407 427
35. P.D. Senter Potent antibody drug conjugates for cancer therapy Curr. Opin. Chem. Biol. 13 2009 235 244
36. S.C. Alley, N.M. Okeley, and P.D. Senter Antibody-drug conjugates: Targeted drug delivery for cancer Curr. Opin. Chem. Biol. 14 2010 529 537
37. J. Caravella, and A. Lugovskoy Design of next-generation protein therapeutics Curr. Opin. Chem. Biol. 14 2010 520 528
38. J.M. Lambert Antibody-maytansinoid conjugates: A new strategy for the trreatment of cancer Drugs Future 35 2010 471 480
39. I. Kümler, C. Ehlers Mortensen, and D.L. Nielsen Trastuzumab emtansine: Tumor-activated prodrug (tap) immunoconjugate oncolytic Drugs Future 36 2011 825 834
40. L. Margulis, and K.V. Schwartz Five kingdoms, an illustrated guide to the phyla of life on earth 2nd ed. 1988 W. H. Freeman & Co. New York
41. D.J. Faulkner Marine natural products Nat. Prod. Rep. 17 2000 7 55
42. J.W. Blunt, B.R. Copp, R.A. Keyzers, M.H.G. Munro, and M.R. Prinsep Marine natural products Nat. Prod. Rep. 29 2012 144 222
43. D.J. Newman, and G.M. Cragg Marine natural products and related compounds in clinical and advanced preclinical trials J. Nat. Prod. 67 2004 1216 1238
44. W.H. Gerwick, and B.S. Moore Lessons from the past and charting the future of marine natural products drug discovery and chemical biology Chem. Biol. 19 2012 85 98
45. M.S. Wallace Ziconotide: A new nonopioid intrathecal analgesic for the treatment of chronic pain Expert Rev. Neurother. 6 2006 1423 1428
46. G. Bulaj, O. Buczek, I. Goodsell, E.C. Jiminez, J. Kranski, J.S. Nielsen, J.E. Garrett, and B.M. Olivera Efficient oxidative folding of conotoxins and the radiation of venomous cone snails Proc. Natl. Acad. Sci. U. S. A. 100 2003 14562 14568
47. R.J. Clark, M. Akcan, Q. Kaas, N.L. Daly, and D.J. Craik Cyclization of conotoxins to improve their biopharmaceutical properties Toxicon 59 2012 446 455
48. R. Henriquez, G. Faircloth, and C. Cuevas Ecteinascidin 743 (et-743); Yondelis™, Aplidin and Kahalalide F G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 215 240
49. C. Cuevas, and A. Francesch Development of Yondelis® (trabectedin, et-743). A semisynthetic process solves the supply problem Nat. Prod. Rep. 26 2009 322 337
50. (r) G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 291 316
51. C.M. Rath, B. Janto, J. Earl, A. Ahmed, F.Z. Hu, L. Hiller, M. Dahlgren, R. Kreft, F. Yu, J.J. Wolff, H.K. Kweon, M.A. Christiansen, K. Håkansson, R.M. Williams, G.D. Ehrlich, and D.H. Sherman Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product et-743 ACS Chem. Biol. 6 2011 1244 1256
52. M.J. Yu, Y. Kishi, and B.A. Littlefield Discovery of e7389, a fully synthetic macrocyclic ketone analog of halichondrin b G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 241 265
53. D.J. Newman The bryostatins G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 137 150
54. D.J. Newman The bryostatins G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, Fl 199 218
55. M.J. Yu, W. Zheng, B.M. Seletsky, B.A. Littlefield, and Y. Kishi Case history: Discovery of eribulin (halaven™), a halichondrin b analogue that prolongs overall survival in patients with metastatic breast cancer J.A. Macor, Ann. Rept. Med. Chem. vol. 46 2011 Academic Press Amsterdam 227 241
56. J. Cortes, J. O'Shaughnessy, D. Loesch, J.L. Blum, L.T. Vahdat, K. Petrakova, P. Chollet, A. Manikas, V. Diéras, T. Delozier, V. Vladimirov, F. Cardoso, H. Koh, P. Bougnoux, C.E. Dutcus, S. Seegobin, D. Mir, N. Meneses, J. Wanders, and C. Twelves Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (embrace): A phase 3 open-label randomised study Lancet 377 2011 914 923
57. R.J. Morgan Jr., L. Leong, W. Chow, D. Gandara, P. Frankel, A. Garcia, H.J. Lenz, and J.H. Doroshow Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: A California cancer consortium study Invest. New Drugs 30 2012 723 728
58. A. Scriabine Discovery and development of major drugs currently in use R. Landau, B. Achilladelis, A. Scriabine, Pharmaceutical innovation: Revolutionizing human health 1999 Chemical Heritage Press Philadelphia 148 270
59. F.M. Arcamone Anthracyclines G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 299 320
60. F.M. Arcamone Anthracyclines G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 383 405
61. S.M. Hecht Bleomycin group antitumor agents G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 357 381
62. S.M. Hecht Bleomycin group antitumor agents G.M. Cragg, D.G.I. Kingston, D.J. Newman, Antitmor agents from natural products 2012 Taylor and Francis Boca Raton, Fl 451 478
63. W.A. Remers The mitomycins G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 475 497
64. P.R. Hamann, J. Upeslacis, and D.B. Borders Enediynes G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 451 474
65. P.R. Hamann, J. Upeslacis, and D.B. Borders Enediynes G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 575 619
66. M. Prudhomme Staurosporines and structurally related indolocarbazoles as antitumor agents G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton 499 517
67. M. Prudhomme Staurosporines and structurally related indolocarbazoles as antitumor agents G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 647 669
68. H.-J. Knolker, and K.R. Reddy Chemistry and biology of the carbazole alkaloids G.A. Cordell, The alkaloids, chemistry and biology vol. 65 2008 Academic Press London 1 430
69. H. Nakano, and S. Omura Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine J. Antibiot. 62 2009 17 26
70. G. Hofle, and H. Reichenbach Epothilone, a myxobacterial metabolite with promising antitumor activity G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2005 Taylor and Francis Boca Raton, FL 413 450
71. G. Hofle, and H. Reichenbach Epothilone, a myxobacterial metabolite with promising antitumor activity G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2012 Taylor and Francis Boca Raton, FL 513 573
72. R.M. Wilson, and S.J. Danishefsky Small molecule natural products in the discovery of therapeutic agents: The synthesis connection J. Org. Chem. 71 2006 8329 8351
73. K.-H. Altmann, and J. Gertsch Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents Nat. Prod. Rep. 24 2007 327 357
74. K.-H. Altmann, B. Pfeifer, S. Arseniyadis, B.A. Pratt, and K.C. Nicolaou The chemistry and biology of epothilones - the wheel keeps turning ChemMedChem 2 2007 396 423
75. M.L. Tse, R.E. Watts, and C. Khosla Substrate tolerance of module 6 of the epothilone synthase Biochemistry 46 2007 3385 3393
76. K.N. Chi, E. Beardsley, B.J. Eigl, P. Venner, S.J. Hotte, E. Winquist, Y.J. Ko, S.S. Sridhar, D. Weber, and F. Saad A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian urologic oncology group study p07a Ann. Oncol. 23 2012 53 58
77. S. McMeekin, R. Patel, C. Verschraegen, P. Celano, J. Burke 2nd, S. Plaxe, P. Ghatage, M. Giurescu, C. Stredder, Y. Wang, and T. Schmelter Phase i/ii study of sagopilone (zk-epo) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer Br. J. Cancer 106 2012 70 76
78. U. Klar, B. Buchmann, W. Schwede, W. Skuballa, J. Hoffman, and R.B. Lichtner Total synthesis and antitumor activity of zk-epo: The first fully synthetic epothilone in clinical development Angew. Chem. Int. Ed. 45 2006
79. D.E. Nix, R.R. Swezey, R. Hector, and J.N. Galgiani Pharmacokinetics of nikkomycin z after single rising oral doses Antimicrob. Agents Chemother. 53 2009 2517 2521
80. M. Debono, and R.S. Gordee Antibiotics that inhibit fungal cell wall development Annu. Rev. Microbiol. 48 1994 471 497
81. N.H. Georgopapadakou, and J.S. Tkacz The fungal cell wall as a drug target Trends Microbiol. 3 1995 98 104
82. M. Debono, W.W. Turner, L. LaGrandeur, F.J. Burkhardt, J.S. Nissen, K.K. Nichols, M.J. Rodriguez, M.J. Zweifel, D.J. Zeckner, R.S. Gordee, J. Tang, and T.R. Parr Jr. Semisynthetic chemical modification of the antifungal lipopeptide echinocandin b (ecb): Structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ecb J. Med. Chem. 38 1995 3271
83. R.E. Schwartz, D.F. Sesin, H. Joshua, K.E. Wilson, A.J. Kempf, K.A. Goklen, D. Kuehner, P. Gailliot, C. Gleason, R. White, E. Inamine, G. Bills, P. Salmon, and L. Zitano Pneumocandins from Zalerion arboricola I. Discovery and isolation J. Antibiot. 45 1992 1853 1866
84. P.S. Masurekar, J.M. Fountoulakis, T.C. Hallada, M.S. Sosa, and L. Kaplan Pneumocandins from Zalerion arboricola II. Modification of product spectrum by mutation and medium manipulation J. Antibiot. 45 1992 1867 1874
85. D.M. Schmatz, G. Abruzzo, M.A. Powles, D.C. McFadden, J.M. Balkovec, R.M. Black, K. Nollstadt, and K. Bartizal Pneumocandins from Zalerion arboricola IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species J. Antibiot. 45 1992 1886 1891
86. K. Bartizal, G. Abruzzo, C. Trainor, D. Krupa, K. Nollstadt, D. Schmatz, R. Schwartz, M. Hammond, J. Balkovec, and F. Vanmiddlesworth In vitro antifungal activities and in vivo efficacies of 1,3-beta-d-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin b, and L-687,781, a papulacandin Antimicrob. Agents Chemother. 36 1992 1648 1657
87. M.B. Kurtz, and J.H. Rex Glucan synthase inhibitors as antifungal agents Adv. Protein Chem. 36 2001 423 475
88. J. Mohr, M. Johnson, T. Cooper, J.S. Lewis II, and L. Ostrosky-Zeicher Current options in antifungal pharmacotherapy Pharmacotherapy 28 2008 614 645
89. S.K. Pitman, R.H. Drew, and J.R. Perfect Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations Exp. Opin. Emerging Drugs 16 2011 559 586
90. T. Roemer, D. Xu, S.B. Singh, C.A. Parish, G. Harris, H. Wang, J.E. Davies, and G.F. Bills Confronting the challenges of natural product-based antifungal discovery Chem. Biol. 18 2011 148 164
91. C.J. Ingham, and P.M. Schneeburger Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities PLoS One 7 2012 e35478
92. J.W. Daly, T.F. Spande, and H.M. Garrafo Alkaloids from amphibian skins. A tabulation of over eight hundred compounds J. Nat. Prod. 68 2005 1556 1575
93. J. Eng, W.A. Kleinman, L. Singh, G. Singh, and J.-P. Raufman Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspecturn venom J. Biol. Chem. 267 1992 7402 7405
94. B. Gallwitz Liraglutide Drugs Future 33 2008 13 20
95. D.J. Newman, and G.M. Cragg Natural products as sources of new drugs over the 30 years from 1981 to 2010 J. Nat. Prod. 75 2012 311 338
96. M. Rouhi Rediscovering natural products Chem. Eng. News 81 41 2003 77 91
97. S. Borman Improving efficiency Chem. Eng. News 84 25 2006 56 78
98. S. Borman Organic lab sparks drug discovery Chem. Eng. News 80 40 2002 23 24
99. R.M. Wilson, and S.J. Danishefsky Applications of total synthesis to problems in neurodegeneration: Fascinating chemistry along the way Acc. Chem. Res. 39 2006 539 549
100. L. Meijer Le cycle de division cellulaire et sa regulation Oncologie 5 2003 311 326
101. G.M. Cragg, and D.J. Newman Natural product sources of drugs: Plants, microbes, marine organisms and animals P.D. Kennewell, D. Triggle, J. Taylor, Comprehensive medicinal chemistry II vol. 1 2006 Elsevier Oxford 355 403
102. M.F. Balandrin, A.D. Kinghorn, and N.R. Farnsworth Plant-derived natural products in drug discovery and development A.D. Kinghorn, M.F. Balandrin, Human medicinal agents from plants vol. 534 1993 Amer. Chem. Soc. Washington, DC 2 12
103. I. Raskin, D.M. Ribnicky, S. Komarnytsky, N. Ilic, A. Poulev, N. Borisjuk, A. Brinker, D.A. Moreno, C. Ripoll, N. Yakoby, J.M. O'Neal, T. Cornwell, I. Pastor, and B. Fridlander Plants and human health in the twenty-first century Trends Biotechnol. 20 2002 522 531
104. D.J. Newman, and R.T. Hill New drugs from marine microbes: The tide is turning J. Ind. Microbiol. Biotechnol. 33 2006 539 544
105. N.B. Perry, L. Ettouati, M. Litaudon, J.W. Blunt, and M.H.G. Munro Alkaloids from the Antarctic sponge Kirkpatrickia varialosa.: Part 1: Variolin B, a new antitumour and antiviral compound. Tetrahedron 50 1994 3987 3992
106. G. Trimurtulu, D.J. Faulkner, N.B. Perry, L. Ettouati, M. Litaudon, J.W. Blunt, M.H.G. Munro, and G.B. Jameson Alkaloids from the Antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin a and n(3′)-methyl tetrahydrovariolin B Tetrahedron 50 1994 3993 4000
107. A. Ahaidar, D. Fernández, G. Danelón, C. Cuevas, I. Manzanares, F. Albericio, J.A. Joule, and M. Álvarez Total syntheses of variolin B and deoxyvariolin B J. Org. Chem. 68 2003 10020 10029
108. T. Diyabalanage, C.D. Amsler, J.B. McClintock, and B.J. Baker Palmerolide A, a cytotoxic macrolide from the Antarctic tunicate Synoicum adareanum J. Am. Chem. Soc. 128 2006 5630 5631
109. K.C. Nicolaou, R. Guduru, Y.-P. Sun, B. Banerji, and D.Y.K. Chen Synthesis of the originally proposed and revised structures of palmerolide A Angew. Chem. Int. Ed. 46 2007 5896 5900
110. Z.E. Wilson, and M.A. Brimble Molecules derived from the extremes of life Nat. Prod. Rep. 26 2009 44 71
111. A. Poulev, J.M. O'Neal, S. Logendra, R.B. Pouleva, V. Timeva, A.S. Garvey, D. Gleba, I.S. Jenkins, B.T. Halpern, R. Kneer, G.M. Cragg, and I. Raskin Elicitation, a new window into plant chemodiversity and phytochemical drug discovery J. Med. Chem. 2003 2542 2547
112. E. McCoy, and S.E. O'Connor Directed biosynthesis of alkaloid analogs in the medicinal plant Catharanthus roseus J. Am. Chem. Soc. 128 2006 14276 14277
113. J.J. Maresh, L.-A. Giddings, A. Friedrich, E.A. Loris, S. Panjikar, B.L. Trout, J. Stöckigt, B. Peters, and S.E. O'Connor Strictosidine synthase: Mechanism of a Pictet-Spengler catalyzing enzyme J. Am. Chem. Soc. 130 2008 710 723
114. E. McCoy, and S.E. O'Connor Natural products from plant cell cultures Prog. Drug Res. 65 2008 330 370
115. L.-A. Giddings, D.K. Liscombe, J.P. Hamilton, K.L. Childs, D. DellaPenna, C.R. Buell, and S.E. O'Connor A stereoselective hydroxylation step of alkaloid biosynthesis by a unique cytochrome p450 in Catharanthus roseus J. Biol. Chem. 286 2011 16751 16757
116. D.K. Liscombe, and S.E. O'Connor A virus-induced gene silencing approach to understanding alkaloid metabolism in Catharanthus roseus Phytochemistry 72 2011 1969 1977
117. Y.-M. Xu, S. Gao, D.P. Bunting, and A.A.L. Gunatilaka Unusual withanolides from aeroponically grown Withania somnifera Phytochemistry 72 2011 518 522
118. N.R. Pace A molecular view of microbial diversity and the biosphere Science 276 1997 734 740
119. M.T. Madigan, J.M. Martinko, and J.B. Parker Biology of microorganisms 8th ed. 1996 Prentice-Hall Upper Saddle River, NJ
120. J.B. McAlpine, B.O. Bachmann, M. Piraee, S. Tremblay, A.-M. Alarco, E. Zazopoulos, and C.M. Farnet Microbial genomics as a guide to drug discovery and structural elucidation: Eco-02301, a novel antifungal agent, as an example J. Nat. Prod. 68 2005 493 496
121. S. Lautru, R.J. Deeth, L. Bailey, and G.M. Challis Discovery of a new peptide natural product by Streptomyces coelicolor genome mining Nat. Chem. Biol. 1 2005 265 269
122. K. Zengler, G. Toledo, M. Rappe, J. Elkins, E.J. Mathur, J.M. Short, and M. Keller Cultivating the uncultured Proc. Natl. Acad. Sci. U. S. A. 99 2002 15681 15686
123. D.W. Udwary, L. Zeigler, R.N. Asolkar, V. Singan, A. Lapidus, W. Fenical, P.R. Jensen, and B.S. Moore Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica Proc. Natl. Acad. Sci. U. S. A. 104 2007 10376 10381
124. M. Nett, H. Ikeda, and B.S. Moore Genomic basis for natural product biosynthetic diversity in the actinomycetes Nat. Prod. Rep. 26 2009 1362 1384
125. E.A. Gontang, W. Fenical, and P.R. Jensen Phylogenetic diversity of Gram-positive bacteria cultured from marine sediments Appl. Environ. Microbiol. 73 2007 3272 3282
126. J.F. Sanchez, A.D. Somoza, N.P. Keller, and C.C.C. Wang Advances in Aspergillus secondary metabolite research in the post-genomic era Nat. Prod. Rep. 29 2012 351 371
127. M.R. Rondon, P.R. August, A.D. Bettermann, S.F. Brady, T.H. Grossman, M.R. Liles, K.A. Loiacono, B.A. Lynch, I.A. MacNeil, C. Minor, C.L. Tiong, M. Gilman, M.S. Osburne, J. Clardy, J.M. Handelsman, and R.M. Goodman Cloning the soil metagenome: A strategy for accessing the genetic and functional diversity of uncultured microorganisms Appl. Environ. Microbiol. 66 2000 2541 2547
128. J.C. Venter, K. Remington, J.F. Heidelberg, A.L. Halpern, D. Rusch, J.A. Eisen, D. Wu, I. Paulsen, K.E. Nelson, W. Nelson, D.E. Fouts, S. Levy, A.H. Knap, M.W. Lomas, K. Nealson, O. White, J. Peterson, J. Hoffman, R. Parsons, H. Baden-Tillson, C. Pfannkoch, Y.-H. Rogers, and H.O. Smith Environmental genome shotgun sequencing of the Sargasso sea Science 304 2004 66 74
129. S.F. Brady, L. Simmons, J.H. Kim, and E.W. Schmidt Metagenomic approaches to natural products from free-living and symbiotic organisms Nat. Prod. Rep. 26 2009 1488 1503
130. S. Yooseph, G. Sutton, D.B. Rusch, A.L. Halpern, S.J. Williamson, K. Remington, J.A. Eisen, K.B. Heidelberg, G. Manning, W. Li, L. Jaroszewski, P. Cieplak, C.S. Miller, H. Li, S.T. Mashiyama, M.P. Joachimiak, C. van Belle, J.-M. Chandonia, D.A. Soergel, Y. Zhai, K. Natarajan, S. Lee, B.J. Raphael, B. Bafna, R. Friedman, S.E. Brenner, A. Godzik, D. Eisenberg, J.E. Dixon, S.S. Taylor, R.L. Strausberg, M. Frazier, and J. Craig Venter The Sorcerer II global ocean sampling expedition: Expanding the universe of protein families PLoS Biol. 5 2007 e16
131. C. Holden Life in the air Science 307 2005 1558
132. J. Crawford, and J. Clardy Microbial genome mining answers longstanding biosynthetic questions Proc. Natl. Acad. Sci. U. S. A. 109 2012 7589 7590
133. J. Piel Metabolites from symbiotic bacteria Nat. Prod. Rep. 26 2009 338 362
134. K. Zimmermann, M. Engeser, J.W. Blunt, M.H.G. Munro, and J. Piel Pederin-type pathways of uncultivated bacterial symbionts: Analysis of o-methyltransferases and generation of a biosynthetic hybrid J. Am. Chem. Soc. 131 2009 2780 2781
135. M. Jin, L. Liu, S.A.I. Wright, S.V. Beer, and J. Clardy Structural and functional analysis of pantocin A: An antibiotic from Pantoea agglomerans discovered by heterologous expression of cloned genes Angew. Chem. Int. Ed. 42 2003 2898 2901
136. F. Abe, and K. Horikoshi The biotechnological potential of piezophiles Trends Biotechnol. 19 2001 102 108
137. 2 lake Chem. Eng. News 84 38 2006 14
138. A. Persidis Extremophiles Nat. Biotechnol. 16 1998 593 594
139. M. Rossi, M. Ciaramella, R. Cannio, F.M. Pisani, M. Moracci, and S. Bartolucci Extremophiles 2002 J. Bacteriol. 185 2003 3683 3689
140. P.L. Short New Zealand plays to its strengths Chem. Eng. News 85 4 2007 20 21
141. R. Cavicchioli, K.S. Siddiqui, D. Andrews, and K.R. Sowers Low-temperature extremophiles and their applications Curr. Opin. Biotechnol. 13 2002 253 261
142. C. Schiraldi, and M. De Rosa The production of biocatalysts and biomolecules from extremophiles Trends Biotechnol. 20 2002 515 521
143. B. van den Burg Extremophiles as a source for novel enzymes Curr. Opin. Microbiol. 6 2003 213 218
144. J. Gomes, and W. Steiner The biocatalytic potential of extremophiles and extremozymes Food Technol. Biotechnol. 42 2004 223 235
145. A. Hoyoux, V. Blaise, T. Collins, S. D'Amico, E. Gratia, A.L. Huston, J.C. Marx, G. Sonan, Y.X. Zeng, G. Feller, and C. Gerday Extreme catalysts from low-temperature environments J. Biosci. Bioeng. 98 2004 317 330
146. J. Wiegel, and V.V. Kevbrin Alkalithermophiles Biochem. Soc. Trans. 32 2004 193 198
147. D.B. Johnson, and K.B. Hallberg The microbiology of acidic mine waters Res. Microbiol. 154 2003 466 473
148. A.A. Stierle, D.B. Stierle, and K. Kemp Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile J. Nat. Prod. 67 2004 1392 1395
149. D.B. Stierle, A.A. Stierle, D. Hobbs, J. Stokken, and J. Clardy Berkeleydione and berkeleytrione, new bioactive metabolites from an acid mine organism Org. Lett. 6 2004 1049 1052
150. A.A. Stierle, and D.B. Stierle Bioprospecting in the Berkeley pit: Bioactive metabolites from acid mine waste extremophiles Stud. Nat. Prod. Chem. 32 2005 1123 1175
151. D.B. Stierle, A.A. Stierle, B. Patacini, K. McIntyre, T. Girtsman, and E. Bolstad Berkeleyones and related meroterpenes from a deep water acid mine waste fungus that inhibit the production of interleukin 1-β from induced inflammasomes J. Nat. Prod. 74 2011 2273 2277
152. R.X. Tan, and W.X. Zou Endophytes: A rich source of functional metabolites Nat. Prod. Rep. 18 2001 448 459
153. G. Strobel, B. Daisy, U. Castillo, and J. Harper Natural products from endophytic microorganisms J. Nat. Prod. 67 2004 257 268
154. A.A.L. Gunatilaka Natural products from plant-associated microorganisms: Distribution, structural diversity, bioactivity, and implications of their occurrence J. Nat. Prod. 69 2006 509 526
155. U. Castillo, J.K. Harper, G.A. Strobel, J. Sears, K. Alesi, E. Ford, J. Lin, M. Hunter, M. Maranta, H. Ge, D. Yaver, J.B. Jensen, H. Porter, R. Robinson, D. Millar, W.M. Hess, M. Condron, and D. Teplow Kakadumycins, novel antibiotics from Streptomyces sp. NRRL 30566, an endophyte of Grevillea pteridifolia FEMS Microbiol. Lett. 224 2003 183 190
156. J.Y. Li, J.K. Harper, D.M. Grant, B.O. Tombe, B. Bashyal, W.M. Hess, and G.A. Strobel Ambuic acid, a highly functionalized cyclohexenone with antifungal activity from Pestalotiopsis spp. and Monochaetia sp Phytochemistry 56 2001 463 468
157. G.-X. Zhou, E.M.K. Wijeratne, D. Bigelow, L.S. Pierson III, H.D. VanEtten, and A.A.L. Gunatilaka Aspochalasins i, j, and k: Three new cytotoxic cytochalasans of Aspergillus flavipes from the rhizosphere of Ericameria laricifolia of the sonoran desert J. Nat. Prod. 67 2004 328 332
158. A. Stierle, G. Strobel, and D. Stierle Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of pacific yew Science 260 1993 214 216
159. J.-Y. Li, R.S. Sidhu, A. Bollon, and G.A. Strobel Stimulation of taxol production in liquid cultures of Pestalotiopsis microspora Mycol. Res. 102 1998 461 464
160. S.C. Puri, V. Verma, T. Amna, G.N. Qazi, and M. Spiteller An endophytic fungus from Nothapodytes foetida that produces camptothecin J. Nat. Prod. 68 2005 1717 1719
161. T. Amna, S.C. Puri, V. Verma, J.P. Sharma, R.K. Khajuria, J. Musarrat, M. Spiteller, and G.N. Qazi Bioreactor studies on the endophytic fungus Entrophosphora infrequens for the production of an anticancer alkaloid camptothecin Can. J. Microbiol. 52 2006 189 196
162. A.L. Eyberger, R. Dondapati, and J.R. Porter Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin J. Nat. Prod. 69 2006 1121 1124
163. S.C. Puri, A. Nazir, R. Chawla, R. Arora, S. Riyaz-ul-Hasan, T. Amna, B. Ahmed, V. Verma, S. Singh, R. Sagar, A. Sharma, R. Kumar, R.K. Sharma, and G.N. Qazi The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related tetralin lignans J. Biotechnol. 122 2006 494 510
164. B. Guo, H. Li, and L. Zhang Isolation of a fungus producing vinblastine J. Yunnan Univ. 20 1998 214 215
165. L.Q. Zhang, B. Guo, H. Li, S. Zeng, H. Shao, S. Gu, and R. Wei Preliminary study on the isolation of endophytic fungus of Catharanthus roseus and its fermentation to produce products of therapeutic value Zhong Cao Yao (Chinese Tradit. Herb. Drugs) 31 2000 805 807
166. X. Yang, L. Zhang, B. Guo, and S. Guo Preliminary study of a vincristine-producing endophytic fungus isolated from leaves of Catharanthus roseus Zhong Cao Yao (Chinese Tradit. Herb. Drugs) 35 2004 79 81
167. J.W. Bok, D. Hoffmeister, L.A. Maggio-Hall, R. Murillo, J.D. Glasner, and N.P. Keller Genomic mining for Aspergillus natural products Chem. Biol. 13 2006 31 37
168. D. Hoffmeister, and N.P. Keller Natural products of filamentous fungi: Enzymes, genes, and their regulation Nat. Prod. Rep. 24 2007 393 416
169. T.J. Mincer, P.R. Jensen, C.A. Kauffman, and W. Fenical Widespread and persistent populations of a major new marine Actinomycete taxon in ocean sediments Appl. Environ. Microbiol. 68 2002 5005 5011
170. R.H. Feling, G.O. Buchanan, T.J. Mincer, C.A. Kauffman, P.R. Jensen, and W. Fenical Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora Angew. Chem. Int. Ed. 42 2003 355 357
171. H.C. Kwon, C.A. Kauffman, P.R. Jensen, and W. Fenical Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus "Marinispora" J. Am. Chem. Soc. 128 2006 1622 1632
172. P.G. Williams, R.N. Asolkar, T. Kondratyuk, J.M. Pezzuto, P.R. Jensen, and W. Fenical Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola J. Nat. Prod. 70 2007 83 88
173. D.C. Oh, W.K. Strangman, C.A. Kauffman, P.R. Jensen, and W. Fenical Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassopira sp Org. Lett. 9 2007 1525 1528
174. C.C. Hughes, and W. Fenical Antibacterials from the sea Chem. Eur. J. 16 2010 12512 12525
175. A.L. Waters, R.T. Hill, A.R. Place, and M.T. Hamann The expanding role of marine microbes in pharmaceutical development Curr. Opin. Biotechnol. 21 2010 780 786
176. R.K. Pettit Culturability and secondary metabolite diversity of extreme
177. J. Piel Metabolites from symbiotic bacteria Nat. Prod. Rep. 21 2004 519 538
178. J. Piel, D. Butzke, N. Fusetani, D. Hui, M. Platzer, G. Wen, and S. Matsunaga Exploring the chemistry of uncultivated bacterial symbionts: Antitumor polyketides of the pederin family J. Nat. Prod. 68 2005 472 479
179. J. Piel, I. Hofer, and D. Hui Evidence for a symbiosis island involved in horizontal acquisition of pederin biosynthetic capabilities by the bacterial symbiont of Paederus fuscipes beetles J. Bacteriol. 186 2004 1280 1286
180. J. Piel, D. Hui, G. Wen, D. Butzke, M. Platzer, N. Fusetani, and S. Matsunaga Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei Proc. Natl. Acad. Sci. U. S. A. 101 2004 16222 16227
181. O.K. Radjasa, Y.M. Vaske, G. Navarro, H.C. Vervoort, K. Tenney, R.G. Linington, and P. Crews Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associants Bioorg. Med. Chem. 19 2011 6658 6674
182. L.P. Partida-Martinez, and C. Hertweck Pathogenic fungus harbours endosymbiotic bacteria for toxin production Nature 437 2005 884 888
183. L.P. Partida-Martinez, C.F. De Looss, K. Ishida, M. Ishida, M. Roth, K. Buder, and C. Hertweck Rhizonin, the first mycotoxin isolated from the zygomycota, is not a fungal metabolite but is produced by bacterial endosymbionts Appl. Environ. Microbiol. 73 2007 793 797
184. L.P. Partida-Martinez, I. Groth, I. Schmitt, W. Richter, M. Roth, and C. Hertweck Burkholderia rhizoxinica sp. nov. and Burkholderia endofungorum sp. nov., bacterial endosymbionts of the plant-pathogenic fungus Rhizopus microsporous Int. J. Syst. Evol. Microbiol. 57 2007 2583 2590
185. G. Lackner, N. Möbius, K. Scherlach, L.P. Partida-Martinez, R. Winkler, I. Schmitt, and C. Hertweck Global distribution and evolution of a toxinogenic Burkholderia-Rhizopus symbiosis Appl. Environ. Microbiol. 75 2009 2982 2986
186. C. Khosla Natural product biosynthesis: A new interface between enzymology and medicine J. Org. Chem. 65 2000 8127 8133
187. J. Staunton, and K.J. Weissman Polyketide biosynthesis: A millennium review Nat. Prod. Rep. 18 2001 380 416
188. C.T. Walsh Polyketide and nonribosomal peptide antibiotics: Modularity and versatility Science 303 2004 1805 1810
189. C.T. Walsh The chemical versatility of natural-product assembly lines Acc. Chem. Res. 41 2007 4 10
190. J. Clardy, and C.T. Walsh Lessons from natural molecules Nature 432 2004 829 837
191. S.G. Van Lanen, and B. Shen Combinatorial biosynthesis of anticancer natural products G.M. Cragg, D.G.I. Kingston, D.J. Newman, Anticancer agents from natural products 2nd ed. 2012 Taylor and Francis Boca Raton, FL 671 698
192. B. Julien, S. Shah, R. Ziemann, R. Goldman, L. Katz, and C. Khosla Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum Gene 249 2000 153 160
193. I. Molnar, T. Schupp, M. Ono, R.E. Zirkle, M. Milnamow, B. Nowak-Thompson, N. Engel, C. Toupet, A. Stratmann, D.D. Cyr, J. Gorlach, J.M. Mayo, A. Hu, S. Goff, J. Schmid, and J.M. Ligon The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum so ce90 Chem. Biol. 7 2000 97 109
194. J. Lau, S. Frykman, R. Regentin, S. Ou, H. Tsuruta, and P. Licari Optimizing the heterologous production of epothilone D in Myxococcus xanthus Biotechnol. Bioeng. 78 2002 280 288
195. K.C. Nicolaou, D. Vourloumis, N. Winssinger, and P.S. Baran The art and science of total synthesis at the dawn of the twenty-first century Angew. Chem. Int. Ed. 39 2000 44 122
196. J. Li, A.W.G. Burgett, L. Esser, C. Amezcua, and P.G. Harran Total synthesis of nominal diazonamides - part 2: On the true structure and origin of natural isolates Angew. Chem. Int. Ed. 40 2001 4770 4773
197. M. Freemantle Scaled-up synthesis of discodermolide Chem. Eng. News 82 9 2004 33 35
198. 7-24 and finale. Org. Process Res. Dev. 8 2004 122 130
199. A. Copeland, and A. Younes Brentuximab vedotin Drugs Future 35 2010 797 801
200. A.J. Singh, M. Razzak, P. Teesdale-Spittle, T.N. Gaitanos, A. Wilmes, I. Paterson, J.M. Goodman, J.H. Miller, and P.T. Northcote Structure-activity studies of the pelorusides: New congeners and semi-synthetic analogues Org. Biomol. Chem. 9 2011 4456 4466
201. I. Paterson, G.J. Naylor, N.M. Gardner, E. Guzmán, and A.E. Wright Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol Chem. Asian J. 6 2011 459 473
202. S.M. Dalby, and I. Paterson Synthesis of polyketide natural products and analogs as promising anticancer agents Curr. Opin. Drug Discov. Dev. 13 2010 777 794
203. A.B. Smith III, C. Sfouggatakis, C.A. Risatti, J.B. Sperry, W. Zhu, V.A. Doughty, T. Tomioka, D.B. Gotchev, C.S. Bennett, S. Sakamoto, O. Atasoylu, S. Shirakami, D. Bauer, M. Takeuchi, J. Koyanagi, and Y. Sakamoto Spongipyran synthetic studies. Evolution of a scalable total synthesis of (+)-spongistatin 1 Tetrahedron 65 2009 6489 6509
204. I.B. Seiple, S. Su, I.S. Young, C.A. Lewis, J. Yamaguchi, and P.S. Baran Total synthesis of palau'amine Angew. Chem. Int. Ed. 49 2010 1095 1098
205. K.C. Nicolaou, S. Kim, J.A. Pfefferkorn, J. Xu, T. Oshima, S. Hosokawa, and T. Li Synthesis and biological activity of sarcodictyins Angew. Chem. Int. Ed. 37 1998 1418 1421
206. B.E. Evans, K.E. Rittle, M.G. Bock, R.M. DiPardo, R.M. Fredinger, W.L. Whitter, G.F. Lundell, D.F. Veber, P.S. Anderson, R.S.L. Chang, V.J. Lotti, D.J. Cerino, T.B. Chen, P. Kling, K.A. Kunkel, J.P. Springer, and J. Hirshfield Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists J. Med. Chem. 1988 2235 2246
207. M.A. Koch, and H. Waldmann Protein structure similarity clustering and natural product structure as guiding principles in drug discovery Drug Discov. Today 10 2005 471 483
208. K.C. Nicolaou, J.A. Pfefferkorn, A.J. Roecker, G.-Q. Cao, S. Barluenga, and H.J. Mitchell Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans J. Am. Chem. Soc. 122 2000 9939 9953
209. K.C. Nicolaou, J.A. Pfefferkorn, S. Barluenga, H.J. Mitchell, A.J. Roecker, and G.-Q. Cao Natural product-like combinatorial libraries based on privileged structures. 3. The "libraries from libraries" principle for diversity enhancement of benzopyran libraries J. Am. Chem. Soc. 122 2000 9968 9976
210. K.C. Nicolaou, J.A. Pfefferkorn, H.J. Mitchell, A.J. Roecker, S. Barluenga, G.Q. Cao, R.L. Affleck, and J.E. Lillig Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using nanokans and optical encoding J. Am. Chem. Soc. 122 2000 9954 9967
211. S. Borman The many faces of combinatorial chemistry Chem. Eng. News 81 43 2003 45 56
212. S. Borman Rescuing combichem. Diversity-oriented synthesis (dos) aims to pick up where traditional combinatorial chemistry left off. Chem. Eng. News 82 40 2004 32 40
213. G.M. Cragg, P.G. Grothaus, and D.J. Newman Impact of natural products on developing new anti-cancer agents Chem. Rev. 109 2009 3012 3043
214. S. Wetzel, R.S. Bon, K. Kumar, and H. Waldmann Biology-oriented synthesis Angew. Chem. Int. Ed. 50 2011 10800 10826
215. L. Eberhardt, K. Kumar, and H. Waldmann Exploring and exploiting biologically relevant chemical space Curr. Drug Targets 12 2011 1531 1546
216. M.D. Burke, E.M. Berger, and S.L. Schreiber Generating diverse skeletons of small molecules combinatorially Science 302 2003 613 618
217. M.D. Burke, and S.L. Schreiber A planning strategy for diversity-oriented synthesis Angew. Chem. Int. Ed. 43 2004 46 58
218. R. Breinbauer, M. Manger, M. Scheck, and H. Waldmann Natural product guided compound library development Curr. Med. Chem. 9 2002 2129 2145
219. R. Breinbauer, I.R. Vetter, and H. Waldmann From protein domains to drug candidates - natural products as guiding principles in the design and synthesis of compound libraries Angew. Chem. Int. Ed. 41 2002 2878 2890
220. D. Brohm, S. Metzger, A. Bhargava, O. Muller, F. Lieb, and H. Waldmann Natural products are biologically validated starting points in structural space for compound library development: Solid-phase synthesis of dysidiolide-derived phosphatase inhibitors Angew. Chem. Int. Ed. 41 2002 307 311
221. A. Ganesan Natural products as a hunting ground for combinatorial chemistry Curr. Opin. Biotechnol. 15 2004 584 590
222. P. Stahl, L. Kissau, R. Mazitschek, A. Giannis, and H. Waldmann Natural product derived receptor tyrosine kinase inhibitors: Identification of igf1r, tie-2, and vegfr-3 inhibitors Angew. Chem. Int. Ed. 41 2002 1174 1178
223. M. Thutewohl, L. Kissau, B. Popkirova, I.-M. Karaguni, T. Nowak, M. Bate, J. Kuhlmann, O. Muller, and H. Waldmann Solid-phase synthesis and biological evaluation of a pepticinnamin E library Angew. Chem. Int. Ed. 41 2002 3616 3620
224. A. Ganesan The impact of natural products upon modern drug discovery Curr. Opin. Chem. Biol. 12 2008 306 317
225. F. Kopp, C.F. Stratton, L.B. Akella, and D.S. Tan A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion Nat. Chem. Biol. 8 2012 358 365
226. D. Camp, R.A. Davis, M. Campitelli, J. Ebdon, and R.J. Quinn Drug-like properties: Guiding principles for the design of natural product libraries J. Nat. Prod. 75 2012 72 81
227. H.B. Bode, and R. Muller The impact of bacterial genomics on natural product research Angew. Chem. Int. Ed. 44 2005 6828 6846
228. G. Yadav, R.S. Gokhale, and D. Mohanty Towards prediction of metabolic products of polyketide synthases: An in silico analysis PLoS Comput. Biol. 5 2009 e1000351
229. A.L. Lane, and B.S. Moore A sea of biosynthesis: Marine natural products meet the molecular age Nat. Prod. Rep. 28 2011 411 428
230. D.L. Akey, J.J. Gehret, D. Khare, and J.L. Smith Insights from the sea: Structural biology of marine polyketide synthases Nat. Prod. Rep. 29 2012 1038 1049
231. A.H. Banskota, J.B. Mcalpine, D. Sørensen, A. Ibrahim, M. Aouidate, M. Piraee, A.M. Alarco, C.M. Farnet, and E. Zazopoulos Genomic analyses lead to novel secondary metabolites. Part 3. Eco-0501, a novel antibacterial of a new class J. Antibiot. 59 2006 533 542
232. J. Clardy, M.A. Fischbach, and C.T. Walsh New antibiotics from bacterial natural products Nat. Biotechnol. 24 2006 1541 1550
233. K.S. Lam New aspects of natural products in drug discovery Trends Microbiol. 15 2007 279 289
234. S. Rachid, K. Gerth, I. Kochems, and R. Muller Deciphering regulatory mechanisms for secondary metabolite production in the myxobacterium Sorangium cellulosum so ce56 Mol. Microbiol. 63 2007 1783 1796
235. J. Herrmann, Y.A. Elnakady, R.M. Wiedmann, A. Ullrich, M. Rohde, U. Kazmaier, A.M. Vollmar, and R. Müller Pretubulysin: From hypothetical biosynthetic intermediate to potential lead in tumor therapy PLoS One 7 2012 e37416
236. J. Wang, S.M. Soisson, K. Young, W. Shoop, S. Kodali, A. Galgoci, R. Painter, G. Parthasarathy, Y.S. Tang, R. Cummings, S. Ha, K. Dorso, M. Motyl, H. Jayasuriya, J. Ondeyka, K. Herath, C. Zhang, L. Hernandez, J. Allocco, A. Basilio, J.R. Tormo, O. Genilloud, F. Vicente, F. Pelaez, L. Colwell, S.H. Lee, B. Michael, T. Felcetto, C. Gill, L.L. Silver, J.D. Hermes, K. Bartizal, J. Barrett, D. Schmatz, J.W. Becker, D. Cully, and S.B. Singh Platensimycin is a selective fabf inhibitor with potent antibiotic properties Nature 441 2006 358 361
237. H. Jayasuriya, K.B. Herath, C. Zhang, D.L. Zink, A. Basilio, O. Genilloud, M.T. Diez, F. Vicente, I. Gonzalez, O. Salazar, F. Pelaez, R. Cummings, S. Ha, J. Wang, and S.B. Singh Isolation and structure of platencin: A fabh and fabf dual inhibitor with potent broad-spectrum antibiotic activity Angew. Chem. Int. Ed. 2007 4684 4688
238. K. Young, H. Jayasuriya, J.G. Ondeyka, K. Herath, C. Zhang, S. Kodali, A. Galgoci, R. Painter, V. Brown-Driver, R. Yamamoto, L.L. Silver, Y. Zheng, J.I. Ventura, J. Sigmund, S. Ha, A. Basilio, F. Vincente, J.R. Tormo, F. Pelaez, P. Youngman, D. Cully, J.F. Barett, D. Schmatz, S.B. Singh, and J. Wang Discovery of fabh/fabf inhibitors from natural products Antimicrob. Agents Chemother. 50 2006 519 526
239. S.B. Singh, D.L. Zink, J. Huber, O. Genilloud, O. Salazar, M.T. Diez, A. Basilio, F. Vincente, and K.M. Byrne Discovery of lucensimycins A and B from Streptomyces lucensis ma7349 using an antisense strategy Org. Lett. 8 2006 5449 5452
240. K.C. Nicolaou, D. Li, and D.J. Edmonds Total synthesis of platensimycin Angew. Chem. Int. Ed. 45 2006 7086 7090
241. K.C. Nicolaou, D.J. Edmonds, A. Li, and G.S. Tria Asymmetric total syntheses of platensimycin Angew. Chem. Int. Ed. 46 2007 3942 3945
242. K.C. Nicolaou, T. Lister, R.M. Denton, A. Montero, and D.J. Edmonds Adamanta-platensimycin: A bioactive analogue of platensimycin Angew. Chem. Int. Ed. 46 2007 4712 4714
243. C. Zhang, J. Ondeyka, K. Herath, H. Jayasuriya, Z. Guan, D.L. Zink, L. Dietrich, B. Burgess, S.N. Ha, J. Wang, and S.B. Singh Platensimycin and platencin congeners from Streptomyces platensis J. Nat. Prod. 74 2011 329 340
244. G.M. Cragg, F. Katz, D.J. Newman, and J. Rosenthal Legal and ethical issues involving marine biodiscovery and development E. Fattorusso, W.H. Gerwick, O. Taglialatela-Scafati, Handbook of marine natural products vol. 2 2012 Springer Science Dordrecht 1316 1342
245. G.M. Cragg, F. Katz, D.J. Newman, and J. Rosenthal The impact of the united nations convention on biological diversity on natural products research Nat. Prod. Rep. 29 2012 1407 1423
246. D.J. Payne, M.N. Gwynn, D.J. Holmes, and D.L. Pompliano Drugs for bad bugs: Confronting the challenges of antibacterial discovery Nat. Rev. Drug Discov. 6 2007 29 40
247. R. Macarron, M.N. Banks, D. Bojanic, D.J. Burns, D.A. Cirovic, T. Garyantes, D.V.S. Green, R.P. Hertzberg, W.P. Janzen, J.W. Paslay, U. Schopfer, and G.S. Sittampalam Impact of high-throughput screening in biomedical research Nat. Rev. Drug Discov. 10 2011 188 195
248. P. Lang, K. Yeow, A. Nichols, and A. Scheer Cellular imaging in drug discovery Nat. Rev. Drug Discov. 5 2006 343 356
249. M. Suffness, D.J. Newman, and K.M. Snader Discovery and development of antineoplastic agents from natural sources P.J. Scheuer, Bioorganic marine chemistry vol. 3 1989 Springer-Verlag Berlin 132 168
250. N. Sin, K.B. Kim, M. Elofsson, L. Meng, H. Auth, B.H.B. Kwok, and C.M. Crews Total synthesis of the potent proteasome inhibitor epoximicin: A useful tool for understanding proteosome biology Bioorg. Med. Chem. Lett. 9 1999 2283 2288
251. S. Davies, R. Pandian, J. Bolos, and R. Castaner Carfilzomib Drugs Future 34 2009 708 716
252. M.E. Rateb, and R. Ebel Secondary metabolites of fungi from marine habitats Nat. Prod. Rep. 28 2011 290 344
253. J.F. Imhoff, A. Labes, and J. Wiese Bio-mining the microbial treasures of the ocean: New natural products Biotechnol. Adv. 29 2011 468 482
254. J. Berdy Thoughts and facts about antibiotics: Where we are now and where we are heading J. Antibiot. 65 2012 385 395